For decades, scientists have searched for a way to outsmart Lyme disease, a stealthy infection that affects nearly half a million people each year in the U.S. Now, a breakthrough may be within reach.

A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...

In the realm of Lyme disease research, one antibiotic emerged as being highly effective for treatment of acute infection, and ...

Piperacillin, an antibiotic in the same class as penicillin, effectively cured mice of Lyme disease at 100-times less than the effective dose of doxycycline, the current gold standard treatment. At ...

This cat vaccine market report delivers an in-depth analysis of the market's key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its ...

Lyme disease, a disease transmitted when deer ticks feed on infected animals like deer and rodents, and then bite humans, impacts nearly half a million individuals in the U.S. annually.

One vaccine to note is Pfizer and Valneva’s Lyme borreliosis vaccine candidate, VLA15. Annually, Lyme disease is responsible for over 475,000 infections in the US and nearly 130,000 infections in ...

The Massachusetts Department of Public Health reports the majority of tick-borne diseases occur between June and August, but ...